{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:51:27Z","timestamp":1794376287473,"version":"4.9.0"},"reference-count":45,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,2]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Modern IV iron formulations allow treatment of iron deficiency anemia (IDA) with 1 or 2 infusions. Ferric carboxymaltose (FCM) is a widely used IV iron, which causes hypophosphatemia in most of the patients. Osteomalacia and fractures are increasingly recognized after repeated infusions of FCM. It is unknown why ferric derisomaltose (FDI) rarely causes hypophosphatemia. In this study, we compare the effects of FCM and FDI on fracture risk and investigate potential underlying mechanisms explaining the different effects on bone and mineral metabolism. For this aim, fracture rate and osteomalacia were assessed in a cohort of 357 patients treated with either drug, who reported a significantly higher rate of incident osteomalacia or fracture after FCM. These findings were validated in &amp;gt;20\u2009000 patients from the TriNetX database, where FCM treatment was independently associated with a higher fracture risk compared with FDI. The underlying mechanisms were investigated in a mouse model of IDA treated with FCM or FDI, an osteocyte model, and biochemically. FCM caused lower expression of collagen and ossification genes, associated with significantly higher bone iron concentrations than FDI. Electron microscopy showed iron-loaded vesicles in osteoblasts and early osteocytes. FCM but not FDI inhibited the binding of dentin matrix protein 1 to \u03b1V\u03b23-integrin on osteocytes. This is a potential mechanism for reduced bone formation and higher levels of intact fibroblast growth factor 23 after FCM. Our data report that IDA and FCM treatment can directly impair bone formation and increase fracture risk.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/blood.2025031806","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T16:59:05Z","timestamp":1773853145000},"page":"15-30","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":14,"title":["Ferric carboxymaltose increases fracture risk in patients and reduces bone formation in mice with iron deficiency anemia"],"prefix":"10.1182","volume":"148","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2319-2722","authenticated-orcid":false,"given":"Sonja A.","family":"Wagner","sequence":"first","affiliation":[{"name":"1Christian Doppler Laboratory for Iron and Phosphate Biology, Medical University of Innsbruck, Innsbruck, Austria"},{"name":"2Department of Internal Medicine I, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1957-412X","authenticated-orcid":false,"given":"Marlene","family":"Panzer","sequence":"additional","affiliation":[{"name":"1Christian Doppler Laboratory for Iron and Phosphate Biology, Medical University of Innsbruck, Innsbruck, Austria"},{"name":"2Department of Internal Medicine I, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1162-9571","authenticated-orcid":false,"given":"Elke","family":"Pertler","sequence":"additional","affiliation":[{"name":"1Christian Doppler Laboratory for Iron and Phosphate Biology, Medical University of Innsbruck, Innsbruck, Austria"},{"name":"2Department of Internal Medicine I, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Redl","sequence":"additional","affiliation":[{"name":"3Institute of Neuroanatomy, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6152-6515","authenticated-orcid":false,"given":"Martina","family":"Saretto","sequence":"additional","affiliation":[{"name":"2Department of Internal Medicine I, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8690-2774","authenticated-orcid":false,"given":"Benedikt","family":"Schaefer","sequence":"additional","affiliation":[{"name":"2Department of Internal Medicine I, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenz M.","family":"Pammer","sequence":"additional","affiliation":[{"name":"2Department of Internal Medicine I, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Obholzer","sequence":"additional","affiliation":[{"name":"2Department of Internal Medicine I, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4515-0523","authenticated-orcid":false,"given":"Maria R.","family":"Troppmair","sequence":"additional","affiliation":[{"name":"2Department of Internal Medicine I, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Hess","sequence":"additional","affiliation":[{"name":"4Institute of Histology and Embryology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willi","family":"Salvenmoser","sequence":"additional","affiliation":[{"name":"5Institute of Zoology, Leopold-Franzens University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Degenhart","sequence":"additional","affiliation":[{"name":"6University Clinic for Radiology, Core Facility MicroCT, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0571-3796","authenticated-orcid":false,"given":"Marisa","family":"Grossgut","sequence":"additional","affiliation":[{"name":"1Christian Doppler Laboratory for Iron and Phosphate Biology, Medical University of Innsbruck, Innsbruck, Austria"},{"name":"2Department of Internal Medicine I, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heribert","family":"Talasz","sequence":"additional","affiliation":[{"name":"7Institute of Medical Biochemistry, Protein Core Facility, Biocenter, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1646-3256","authenticated-orcid":false,"given":"Klaus","family":"Faserl","sequence":"additional","affiliation":[{"name":"7Institute of Medical Biochemistry, Protein Core Facility, Biocenter, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Sarg","sequence":"additional","affiliation":[{"name":"7Institute of Medical Biochemistry, Protein Core Facility, Biocenter, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Haubner","sequence":"additional","affiliation":[{"name":"8Department of Nuclear Medicine, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6046-0365","authenticated-orcid":false,"given":"Markus A.","family":"Hartmann","sequence":"additional","affiliation":[{"name":"91st Medical Department, Ludwig Boltzmann Institute of Osteology at Hanusch-Hospital of Oesterreichische Gesundheitskasse and Allgemeine Unfallversicherungsanstalt Trauma Centre Meidling, Hanusch Hospital, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6575-8443","authenticated-orcid":false,"given":"St\u00e9phane","family":"Blouin","sequence":"additional","affiliation":[{"name":"91st Medical Department, Ludwig Boltzmann Institute of Osteology at Hanusch-Hospital of Oesterreichische Gesundheitskasse and Allgemeine Unfallversicherungsanstalt Trauma Centre Meidling, Hanusch Hospital, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9205-1440","authenticated-orcid":false,"given":"Verena","family":"Petzer","sequence":"additional","affiliation":[{"name":"10Department of Internal Medicine V-Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Gronich-Wondrak","sequence":"additional","affiliation":[{"name":"2Department of Internal Medicine I, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2945-2946","authenticated-orcid":false,"given":"Andreas","family":"Kronbichler","sequence":"additional","affiliation":[{"name":"11Department of Internal Medicine IV-Nephrology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Manzl","sequence":"additional","affiliation":[{"name":"12Institute of Neuropathology and Neuromolecular Pathology, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Glodny","sequence":"additional","affiliation":[{"name":"6University Clinic for Radiology, Core Facility MicroCT, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4235-2579","authenticated-orcid":false,"given":"Herbert","family":"Tilg","sequence":"additional","affiliation":[{"name":"2Department of Internal Medicine I, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Franke","sequence":"additional","affiliation":[{"name":"13Institute of Clinical Molecular Biology, University Hospital Schleswig-Holstein, Christian Albrecht University Kiel, Kiel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myles","family":"Wolf","sequence":"additional","affiliation":[{"name":"14Weill Department of Medicine, Weill Cornell Medical College, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6200-2675","authenticated-orcid":false,"given":"Michel V.","family":"Hadjihannas","sequence":"additional","affiliation":[{"name":"13Institute of Clinical Molecular Biology, University Hospital Schleswig-Holstein, Christian Albrecht University Kiel, Kiel, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1794-422X","authenticated-orcid":false,"given":"Heinz","family":"Zoller","sequence":"additional","affiliation":[{"name":"1Christian Doppler Laboratory for Iron and Phosphate Biology, Medical University of Innsbruck, Innsbruck, Austria"},{"name":"2Department of Internal Medicine I, Medical University of Innsbruck, Innsbruck, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"20","key":"2026070211221819100_bib1","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1001\/jama.2025.0452","article-title":"Iron deficiency in adults: a review","volume":"333","author":"Auerbach","year":"2025","journal-title":"Jama"},{"issue":"7","key":"2026070211221819100_bib2","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/ajh.27220","article-title":"Expert consensus guidelines: Intravenous iron uses, formulations, administration, and management of reactions","volume":"99","author":"Van Doren","year":"2024","journal-title":"Am J Hematol"},{"issue":"9","key":"2026070211221819100_bib3","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/ajh.25564","article-title":"A prospective, multi-center, randomized comparison of iron isomaltoside 1000 versus iron sucrose in patients with iron deficiency anemia; the FERWON-IDA trial","volume":"94","author":"Auerbach","year":"2019","journal-title":"Am J Hematol"},{"issue":"5","key":"2026070211221819100_bib4","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/j.1572-0241.2007.01744.x","article-title":"A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trial","volume":"103","author":"Kulnigg","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"2026070211221819100_bib5","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s11096-023-01548-2","article-title":"A systematic literature review and meta-analysis of the incidence of serious or severe hypersensitivity reactions after administration of ferric derisomaltose or ferric carboxymaltose","volume":"45","author":"Kennedy","year":"2023","journal-title":"Int J Clin Pharm"},{"issue":"3","key":"2026070211221819100_bib6","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ejpb.2011.03.016","article-title":"A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implications","volume":"78","author":"Jahn","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"issue":"4","key":"2026070211221819100_bib7","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10534-015-9845-9","article-title":"Physico-chemical properties of the new generation IV iron preparations ferumoxytol, iron isomaltoside 1000 and ferric carboxymaltose","volume":"28","author":"Neiser","year":"2015","journal-title":"Biometals"},{"issue":"11","key":"2026070211221819100_bib8","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.3390\/jcm9113587","article-title":"A pooled analysis of serum phosphate measurements and potential hypophosphataemia events in 45 interventional trials with ferric carboxymaltose","volume":"9","author":"Rosano","year":"2020","journal-title":"J Clin Med"},{"issue":"4","key":"2026070211221819100_bib9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/apt.15386","article-title":"Incidence of hypophosphatemia in patients with inflammatory bowel disease treated with ferric carboxymaltose or iron isomaltoside","volume":"50","author":"Detlie","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"2026070211221819100_bib10","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1001\/jama.2019.22450","article-title":"Effects of iron isomaltoside vs ferric carboxymaltose on hypophosphatemia in iron-deficiency anemia: two randomized clinical trials","volume":"323","author":"Wolf","year":"2020","journal-title":"JAMA"},{"issue":"4","key":"2026070211221819100_bib11","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/gutjnl-2022-327897","article-title":"Hypophosphataemia following ferric derisomaltose and ferric carboxymaltose in patients with iron deficiency anaemia due to inflammatory bowel disease (PHOSPHARE-IBD): a randomised clinical trial","volume":"72","author":"Zoller","year":"2023","journal-title":"Gut"},{"key":"2026070211221819100_bib12","doi-asserted-by":"crossref","first-page":"116202","DOI":"10.1016\/j.bone.2021.116202","article-title":"Hypophosphatemia after intravenous iron therapy: comprehensive review of clinical findings and recommendations for management","volume":"154","author":"Schaefer","year":"2022","journal-title":"Bone"},{"issue":"6","key":"2026070211221819100_bib13","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/jbmr.4558","article-title":"Osteomalacia as a complication of intravenous iron infusion: a systematic review of case reports","volume":"37","author":"Vilaca","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2026070211221819100_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41581-019-0189-5","article-title":"FGF23 at the crossroads of phosphate, iron economy and erythropoiesis","volume":"16","author":"Edmonston","year":"2020","journal-title":"Nat Rev Nephrol"},{"issue":"8","key":"2026070211221819100_bib15","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/jbmr.1923","article-title":"Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women","volume":"28","author":"Wolf","year":"2013","journal-title":"J Bone Miner Res"},{"key":"2026070211221819100_bib16","doi-asserted-by":"crossref","first-page":"100862","DOI":"10.1016\/j.mam.2020.100862","article-title":"Intravenous iron supplementation therapy","volume":"75","author":"Schaefer","year":"2020","journal-title":"Mol Aspects Med"},{"issue":"15","key":"2026070211221819100_bib17","doi-asserted-by":"crossref","first-page":"5520","DOI":"10.1073\/pnas.1402218111","article-title":"Dynamic regulation of FGF23 by Fam20C phosphorylation, GalNAc-T3 glycosylation, and furin proteolysis","volume":"111","author":"Tagliabracci","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"2026070211221819100_bib18","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1182\/bloodadvances.2022009524","article-title":"Bone marrow sinusoidal endothelial cells are a site of Fgf23 upregulation in a mouse model of iron deficiency anemia","volume":"7","author":"Li","year":"2023","journal-title":"Blood Adv"},{"issue":"2","key":"2026070211221819100_bib19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11914-015-0259-y","article-title":"Hypophosphatemic rickets: lessons from disrupted FGF23 control of phosphorus homeostasis","volume":"13","author":"Goldsweig","year":"2015","journal-title":"Curr Osteoporos Rep"},{"issue":"11","key":"2026070211221819100_bib20","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ng1905","article-title":"Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism","volume":"38","author":"Feng","year":"2006","journal-title":"Nat Genet"},{"issue":"11","key":"2026070211221819100_bib21","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/ng1868","article-title":"DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis","volume":"38","author":"Lorenz-Depiereux","year":"2006","journal-title":"Nat Genet"},{"issue":"3","key":"2026070211221819100_bib22","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nrc2345","article-title":"Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer","volume":"8","author":"Bellahc\u00e8ne","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"34","key":"2026070211221819100_bib23","doi-asserted-by":"crossref","first-page":"29462","DOI":"10.1074\/jbc.M110.194746","article-title":"Dentin matrix protein 1 (DMP1) signals via cell surface integrin","volume":"286","author":"Wu","year":"2011","journal-title":"J Biol Chem"},{"issue":"5","key":"2026070211221819100_bib24","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/jbmr.294","article-title":"Unique roles of phosphorus in endochondral bone formation and osteocyte maturation","volume":"26","author":"Zhang","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"36","key":"2026070211221819100_bib25","doi-asserted-by":"crossref","first-page":"34700","DOI":"10.1074\/jbc.M305315200","article-title":"Evidence for the proteolytic processing of dentin matrix protein 1. Identification and characterization of processed fragments and cleavage sites","volume":"278","author":"Qin","year":"2003","journal-title":"J Biol Chem"},{"issue":"1-4","key":"2026070211221819100_bib26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000151727","article-title":"Studies of the DMP1 57-kDa functional domain both in vivo and in vitro","volume":"189","author":"Lu","year":"2009","journal-title":"Cells Tissues Organs"},{"issue":"5565","key":"2026070211221819100_bib27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1126\/science.1069040","article-title":"Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand","volume":"296","author":"Xiong","year":"2002","journal-title":"Science"},{"issue":"1","key":"2026070211221819100_bib28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1557\/mrs.2011.329","article-title":"Development of electron energy loss spectroscopy in the biological sciences","volume":"37","author":"Aronova","year":"2012","journal-title":"MRS Bull"},{"issue":"24","key":"2026070211221819100_bib29","doi-asserted-by":"crossref","first-page":"e156850","DOI":"10.1172\/jci.insight.156850","article-title":"FGF23 directly inhibits osteoprogenitor differentiation in Dmp1-knockout mice","volume":"8","author":"Courbon","year":"2023","journal-title":"JCI Insight"},{"issue":"14","key":"2026070211221819100_bib30","doi-asserted-by":"crossref","first-page":"4861","DOI":"10.3390\/jcm14144861","article-title":"Evaluating the risk of hypophosphatemia with ferric carboxymaltose and the recommended approaches for management: a consensus statement","volume":"14","author":"Rosano","year":"2025","journal-title":"J Clin Med"},{"issue":"8","key":"2026070211221819100_bib31","doi-asserted-by":"crossref","first-page":"ziae064","DOI":"10.1093\/jbmrpl\/ziae064","article-title":"Iron and bones: effects of iron overload, deficiency and anemia treatments on bone","volume":"8","author":"von Brackel","year":"2024","journal-title":"JBMR Plus"},{"issue":"3","key":"2026070211221819100_bib32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.11005\/jbm.2017.24.3.161","article-title":"Association between hemoglobin level and bone mineral density in Korean adults","volume":"24","author":"Oh","year":"2017","journal-title":"J Bone Metab"},{"issue":"1","key":"2026070211221819100_bib33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11657-022-01130-9","article-title":"Anemia is associated with increased risk of non-vertebral osteoporotic fractures in elderly men: the MrOS Sweden cohort","volume":"17","author":"Kristjansdottir","year":"2022","journal-title":"Arch Osteoporos"},{"issue":"8","key":"2026070211221819100_bib34","doi-asserted-by":"crossref","first-page":"e2754","DOI":"10.1210\/clinem\/dgae807","article-title":"Increased risk of fracture among patients with iron overload: a population-based matched cohort study","volume":"110","author":"Burden","year":"2024","journal-title":"The J Clin Endocrinol Metab"},{"issue":"2","key":"2026070211221819100_bib35","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s12011-013-9605-z","article-title":"Iron overload inhibits osteoblast biological activity through oxidative stress","volume":"152","author":"He","year":"2013","journal-title":"Biol Trace Elem Res"},{"key":"2026070211221819100_bib36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejpb.2022.03.006","article-title":"Tissue biodistribution of intravenous iron-carbohydrate nanomedicines differs between preparations with varying physicochemical characteristics in an anemic rat model","volume":"174","author":"Funk","year":"2022","journal-title":"Eur J Pharm Biopharm"},{"key":"2026070211221819100_bib37","doi-asserted-by":"crossref","first-page":"107390","DOI":"10.1016\/j.ejps.2025.107390","article-title":"Comparing iron sucrose and ferric carboxymaltose interactions with murine and human macrophages: focus on the lysosomal compartment","volume":"217","author":"Sousa de Almeida","year":"2026","journal-title":"Eur J Pharm Sci"},{"issue":"12","key":"2026070211221819100_bib38","doi-asserted-by":"crossref","first-page":"e0167146","DOI":"10.1371\/journal.pone.0167146","article-title":"Choice of high-dose intravenous iron preparation determines hypophosphatemia risk","volume":"11","author":"Schaefer","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"2026070211221819100_bib39","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1073\/pnas.0902006107","article-title":"Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation","volume":"107","author":"Goetz","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026070211221819100_bib40","doi-asserted-by":"crossref","first-page":"107265","DOI":"10.1016\/j.ejps.2025.107265","article-title":"Distinct roles of ferric carboxymaltose and ferric derisomaltose on phosphate homeostasis in iron deficiency anemia","volume":"214","author":"Dominguez Rieg","year":"2025","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"2026070211221819100_bib41","first-page":"106","article-title":"Bone-derived C-terminal FGF23 cleaved peptides increase iron availability in acute inflammation","volume":"142","author":"Courbon","year":"2023","journal-title":"Blood"},{"issue":"1","key":"2026070211221819100_bib42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood.2023020770","article-title":"Matryoshka hormones","volume":"142","author":"Wolf","year":"2023","journal-title":"Blood"},{"issue":"47","key":"2026070211221819100_bib43","doi-asserted-by":"crossref","first-page":"32730","DOI":"10.1074\/jbc.M804283200","article-title":"Dentin matrix protein-1 isoforms promote differential cell attachment and migration","volume":"283","author":"von Marschall","year":"2008","journal-title":"J Biol Chem"},{"key":"2026070211221819100_bib44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41413-019-0051-1","article-title":"DMP1 prevents osteocyte alterations, FGF23 elevation and left ventricular hypertrophy in mice with chronic kidney disease","volume":"7","author":"Dussold","year":"2019","journal-title":"Bone Res"},{"issue":"12","key":"2026070211221819100_bib45","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1359\/JBMR.050815","article-title":"DMP1 depletion decreases bone mineralization in vivo: an FTIR imaging analysis","volume":"20","author":"Ling","year":"2005","journal-title":"J Bone Miner Res"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/1\/15\/2531391\/blood_bld-2025-031806-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/148\/1\/15\/2531391\/blood_bld-2025-031806-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:32:05Z","timestamp":1783006325000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/148\/1\/15\/567279\/Ferric-carboxymaltose-increases-fracture-risk-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,7,2]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2025031806","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7,2]]},"published":{"date-parts":[[2026,7,2]]}}}